Objective: The objectives of this study are to determine what is the minimal volume required to perform an effective fluid challenge and to investigate how different doses of IV fluids in an fluid challenge affect the changes in cardiac output and the proportion of responders and nonresponders. Design: Quasi-randomized controlled trial. Setting: Cardiothoracic ICU, tertiary university hospital. Patients: Eighty postcardiac surgery patients. Intervention: IV infusion of 1, 2, 3, or 4 mL/Kg (body weight) of crystalloid over 5 minutes. Measurements and Main Results: Mean systemic filling pressure measured using the transient stop-flow arm arterial-venous equilibrium pressure, arterial and central venous pressure, cardiac output (LiDCOplus; LiDCO, Cambridge, United Kingdom), and heart rate. The groups were well matched with respect to demographic and baseline physiologic variables. The proportion of responders increased from 20% in the group of 1 mL/kg to 65% in the group of 4 mL/kg (p = 0.04). The predicted minimal volume required for an fluid challenge was between 321 and 509 mL. Only 4 mL/ Kg increases transient stop-flow arm arterial-venous equilibrium pressure beyond the limits of precision and was significantly associated with a positive response (odds ratio, 7.73; 95% CI, 1.78-31.04).
O ne of the commonest interventions performed in critical care is a fluid challenge (FC). An FC is the administration of a "small" amount of IV fluids, in order to assess the cardiac response to an increase in intravascular volume (1, 2) . Despite the simplicity of this test, it is unclear how much volume should be used to perform an FC. Volumes from 100 mL up to 3 L have been reported in the literature (3), and similar results are observed in clinical practice as reported recently in a large multicentre study about the FC technique with a median volume of 500 mL (500-999 mL) (4) .
The mean systemic filling pressure (Pmsf) is a quantitative measure of the intravascular volume. It is the pressure in the cardiovascular system when there is no blood flow, and it is defined by the relationship between intravascular stress volume and mean vascular capacitance. Guyton et al (5) observed that acute expansion of intravascular volume increases venous return insofar as the increase in volume increases Pmsf. As under steady conditions, venous return equals cardiac output (CO); an effective FC should be able to increase the Pmsf in order to challenge the cardiac response; otherwise, the volume given may have no Current controlled trials registration number: NCT02569008.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (http://journals.lww.com/ ccmjournal).
Dr. Aya received funding from Applied Physiology and LiDCO. Dr. Fletcher disclosed other support (payment received by his institution from BARD for educational course). Dr. Cecconi received funding from Edwards Lifesciences, LiDCO, Deltex, Applied Physiology, Masimo, Bmeye, Cheetah, Imacor (travel expenses, honoraria, advisory board, unrestricted educational grant, research material). He disclosed other support (Consultations for LiDCO Edwards Lifesciences). The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: hollmann.aya@nhs.net 1 about the precision of the measurement of the transient stopflow arm arterial-venous equilibrium pressure (Pmsf-arm) reported a least significant change (LSC) of 14% of baseline value for a single measurement, which is the minimal change that should be observed in order to believe that a real change occurs beyond the limits of precision. We hypothesize that the volume of fluids may affect not only the change in Pmsf but also the change in CO and the proportion of responders to an FC. Thus, the objectives of the present study are, first, to determine what is the minimal volume of IV fluids required to increase the Pmsf-arm by the LSC to perform an effective FC and, second, to determine how different doses of fluids in an FC affect the changes in CO and the proportion of responders.
METHODS
This study was approved by the Camden and Islington Research Ethic Committee (13/LO/1307, December 2013). Written informed consent was obtained from all patients.
Study Design
This is a quasi-randomized (8, 9) , single-blinded, controlled study with an allocation ratio of 1:1. The different arms consisted of doses of 1, 2, 3, and 4 mL/kg (actual body weight) of Compound Sodium Lactate (Hartmann's Solution; Baxter, Thetford, United Kingdom) as an FC infused over 5 minutes manually using a syringe of 60 mL and a timer in the multiparameter monitor. Patients were approached when admitted to hospital before cardiac surgery. The first 20 patients were allocated to receive 1 mL/kg (total body weight), the following 20 to 2 mL/Kg, and so on. Pmsf-arm, mean arterial pressure (MAP), CO, stroke volume (SV), heart rate (HR), and central venous pressure (CVP) were recorded at baseline and after the FC. After the second measurement, the dose of fluids was completed according to the clinical prescription. Clinical indication for an FC was according to the standard clinical postoperative protocol (10) (Supplemental Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/C118).
Participants
Patients admitted to cardiothoracic ICU following cardiac surgery were prospectively enrolled. Patients with occlusive peripheral vascular disease, postoperative valve regurgitation, presence of an intraaortic balloon pump, pregnancy, body weight below 50 kg, absence of radial arterial catheter, evidence or strong suspicious of active bleeding or sepsis and patients requiring fluid resuscitation or changes in vasoactive therapy were excluded from the study. All patients were studied during the initial period in the ICU, once they achieved a hemodynamic and respiratory steady state, defined by changes no greater than 10% in HR, respiratory rate, CO, SV, arterial pressure, and arterial saturation of oxygen for at least 10 minutes.
Measurements
Invasive arterial pressure and CVP were used for the study. Pressure transducers were referenced to the intersection of fifth intercostal space and anterior axillar line and connected to the multiparameter monitor (IntelliVue MX800; Philips Healthcare, Best, The Netherlands) with patients lying fully supine in bed. Pmsf-arm was measured using the transient stop-flow arterial-venous equilibrium method (11) by stopping the blood flow in the arm using a pneumatic tourniquet (AT4 pneumatic tourniquet; AneticAid, Leeds, United Kingdom) to pressures 50-60 mm Hg above systolic pressure and held for 60 seconds. Pmsf-arm is defined as the arterial pressure at 60 seconds of cuff inflation (7) . CO was monitored with a noncalibrated LiDCOplus monitor (version 4.02.92; LiDCO, Cambridge, United Kingdom) or with a pulmonary artery catheter (Edwards Lifesciences, Irvine, CA). Responders are defined as an increase in CO equal or greater than 10% from baseline.
Statistical Analysis
Sample size calculation is described in detail in the supplemental data (Supplemental Digital Content 1, http://links. lww.com/CCM/C118). Descriptive statistics and graphics were used to understand the data structure and the variables nature. Continuous variables are summarized by their means, medians, sds, and/or interquartiles. Categoric or binary variables are summarized in terms of proportions stratified by patients' groups.
Differences Between Dose Groups
The analyses consist of a series of regression models for differences in changes of hemodynamics (i.e., ΔPmsf-arm) on dose of fluids (1, 2, 3, and 4 mL/kg), CO response groups (responders and nonresponders), and adjusted for the hemodynamic of interest at baseline (i.e., Pmsf-arm baseline). The predicted means of the changes in each group adjusted for the mean values of the corresponding baseline are reported after fitting the most parsimonious model. Proportions are compared with a chi-square test.
Determination of Minimal Volume
To determine the minimal volume required to increase Pmsfarm by 14%, stepwise multiple linear regression was used with change of Pmsf-arm as dependent variable. The set of independent predictors explored included Pmsf-arm baseline, volume (mL), weight (Kg), concomitant use of vasodilators (morphine, alfentanil, milrinone, and/or nitroglycerin), diabetes mellitus status, use of extracorporeal circulation (pump) intraoperatively, concomitant use of vasoconstrictors (dopamine, noradrenaline, adrenaline), baseline arterial pressure (MAP), and temperature. To estimate the minimal volume, the model was run to predict the values of ∆Pmsf-arm for all the baseline values, and we choose the volume values (mL) for which the outcome would achieve a 14% increase in the lower bound of the 95% CI. The presence of missing values has been assessed (cardiac echocardiographic parameters), and the data have been analyzed using multiple imputation techniques under missing at random assumption (12) . Fluid responsiveness was also considered as a binary outcome (responders vs nonresponders). A logistic regression was employed to estimate the odds ratio (OR) of responders versus nonresponders by dose of crystalloid 
RESULTS
A total of 119 patients were screened between September 2014 and January 2015. Out of those, 39 did not satisfy the eligibility criteria (Supplemental Fig. 2 (Fig. 1) . This difference is attributable to responders of group 1 (20%) and group 4 (65%). Proportions of responders between groups 1, 2, and 3 mL/kg were not significantly different.
Descriptive statistics of changes in hemodynamics by dose of crystalloids and CO response are presented in Table 1 , and estimated differences by dose of crystalloids and CO response adjusted by baseline values are reported in Table 2 . Predicted changes of hemodynamics adjusted by baseline values are presented in Supplemental Table 2 (Supplemental Digital Content 1, http://links.lww.com/CCM/C118). ΔPmsf-arm was significantly greater with 2, 3, and 4 mL/kg compared to 1 mL/kg (p = 0.007, 0.01, and < 0.001, respectively) (Fig. 2) . The changes on other hemodynamic parameter are explained in detail in the supplemental data (Supplemental Digital Content 1, http:// links.lww.com/CCM/C118).
The regression model of ∆Pmsf-arm (%) revealed as significant predictors Pmsf-arm at baseline and the absolute volume (mL) infused. There is no enough evidence to support a strong effect of the concomitant use of vasodilators on ∆Pmsf-arm (%), however, it was considered clinically relevant and was maintained into the model ( Table 3) . Weight was neither a significant predictor (B, -0.01; 95% CI, -0.19 to 0.16; p = 0.88) nor the interaction with volume (mL) (p = 0.42). An increase of 1 mL of crystalloids increases the ∆Pmsf-arm by 0.05% holding the Pmsf-arm at baseline and the use of vasodilators constant. The estimated volume required to achieve a change in Pmsf-arm of at least 14% in the lower limit of the 95% CI, adjusted by the Pmsf-arm at baseline, is between 321 and 393 mL without vasodilators and between 446 and 509 mL in those patients, where vasodilators were being used (Supplemental Table 3 , Supplemental Digital Content 1, http://links.lww.com/CCM/C118).
There is only some marginal evidence (p = 0.07) to support some differences between patients with severe diastolic dysfunction and those with normal diastolic function of left ventricle (LV) (Supplemental 
DISCUSSION
The findings of this study demonstrate the importance of the volume used for an FC on the effectiveness of this cardiovascular test. Small volumes seem to be less likely to increase the Pmsf-arm, and this affects the ability to identify responders in terms of CO: up to 45% of responders may possibly be misclassified as nonresponders. The change in CO is strongly affected by the dose used and very little affected by the systolic or diastolic function at baseline. The Pmsf-arm at baseline and the volume infused are the major determinants of the change in Pmsf: volumes between 320 and 510 mL, which are fairly equivalent to 4 mL/Kg, seem to be sufficient for an effective FC. When an effective FC is performed, MAP increases along with the CO, and CVP increases in both responders and nonresponders.
The effect of blood volume on Pmsf was already demonstrated in experiments by Guyton et al (5) . The ΔPmsf depends on the change of stressed volume and the capacitance of the vascular system (13), which in turn depends on several factors such as the sympathetic tone, hypercapnia, hypoxia, and aortic and cardiopulmonary chemoreceptors (14) . The Pmsf values reported in this study are similar to previous studies in similar populations (6, 7, 11) , and the baseline values are very similar in the four groups, which reassure that the hemodynamic effect of the intravascular volume was fairly similar on the four groups. Noradrenaline can increase Pmsf and reduce vascular capacitance (15, 16) , but in our study the infusion of vasoconstrictors did not show a significant effect on ∆Pmsf-arm. Conversely, the infusion of vasodilators, although not reaching statistical significance, has a clinical impact on the dose required for a FC, which is explained by the increase in unstressed volume. The volume infused and the Pmsf-arm at baseline explain only 28% of the total variability of the change in Pmsf-arm, which point out the complexity of the regulation of the vascular capacitance: in 24.7% of cases, the Pmsf-arm did not change (only in the group of 1 mL/Kg) after the FC. Capacitance vessels tone, interstitial pressure, and transcapillary fluid flow are some of the relevant factors that could possibly explain the great variability associated to the change of Pmsf. Pmsf at baseline is a significant predictor, inversely related to the change of Pmsf-arm: for 1 mm Hg of increase of Pmsfarm at baseline, the ∆Pmsf-arm will decrease by 0.35 mm Hg. This may suggest that there is a physiologic upper limit for Pmsf regardless the volume given, so that part of the volume is redistributed between stressed and nonstressed compartments or distributed between the intravascular and extravascular space.
In some cases, the CO increases despite an increase of Pmsf below the LSC. This can be explained by the gradient generated between the IV pressure and the mechanical force used to infuse the fluids into the venous system. Small volumes infused at a high rate may push enough blood into the right ventricle (RV), emulating an increase in venous return and testing the preload reserve of the right heart. In addition, other factors associated with the cardiac sensitivity to the change in preload must be taken into consideration: our results suggest that severe diastolic dysfunction may reduce this sensitivity, but these results should be taken with caution as this study was not specifically design to answer this question. The results of our analysis of the CO changes according to the LV or RV function only highlight that the dose of crystalloids used is the main factor that explains the differences in ΔCO.
The changes observed in CVP suggest that this variable cannot be used as a safety limit, as there is no evidence to support the assertion that changes on CVP differ between responders and nonresponders. This is in agreement with a recent study that showed that the overall impact of a FC on the CVP is greater in nonresponders but not the change at any particular time point after the fluid infusion (17) . However, CVP could Our results may bring into question the negative predictive value of small volumes to reliably assess fluid responsiveness.
Muller et al (18) proposed a mini-FC using an infusion of 100 mL of colloids over 1 minute in patients with acute cardiovascular failure. The response was assessed measuring the variation of subaortic variation time index (dVTI) using Doppler echocardiography after 100 mL and then after the infusion of 400 mL of colloids over 14 minutes. The authors proposed a dVTI cutoff of 10%, which had a sensitivity of 95% and specificity of 78% with a negative predictive value of 93%. In contrast with our study, Muller et al (18) chose colloids, which are known to increase CO more than crystalloids (19, 20) . Muller et al (18) used the VTI, which may also be more sensitive and less dependent on accuracy of arterial catheters and, much more importantly, Muller et al (18) studied patients with acute circulatory failure, where all the normal cardiac reflexes may not work properly. Guinot et al (21) reported a similar study using crystalloids and measuring the change in SV (dSV) by thoracic impedance cardiography. A dSV of 7% after 100 mL of crystalloids showed a sensitivity of 89% and specificity of 89% with a negative predictive value of 93%. Another important difference with our study is the method used to assess fluid responsiveness, as we use continuous CO based on pulse power analysis. Mallat et al (22) carried out a similar study in 49 fully sedated patients using the PiCCO device (PiCCO; Pulsion Medical System, Munich, Germany) to measure continuous cardiac index (CCI). The area under the receiver operating characteristic curves for the CCI (dCCI) after 100 mL of colloid infusion over 1 minute was 0.78 with a large gray zone that included 67% of the subjects. For a cutoff value of 5.2% for dCCI after 100 mL, sensitivity was 77% and specificity 74%.
There are some limitations in this study that need to be acknowledged. First, there is a different rate of fluid (23) . It is likely that Pmsf in normal humans is similar to dogs. The baseline Pmsf in this study was 23.6 mm Hg. This higher Pmsf may partly be explained by the higher CVP as the Pmsf must be higher than the CVP to ensure venous return. Nevertheless, the precision of the Pmsf-arm, which is the relevant concept in this study, was studied and reported in a previous study (7) . Third, we used a noncalibrated LiDCOplus monitor, which clearly affects the accuracy of CO measurements. However, this device incorporates two independent systems: the LiDCO lithium dilution technique and the PulseCO pulse power algorithm, which can reliably track changes of CO (24) . Fourth, we selected a fairly homogeneous sample of postoperative cardiac surgery patients that were in a stable hemodynamic state. This was necessary to obtain good quality data and to avoid further variability in the results as cardiovascular compliance can vary significantly in other subpopulations of critically ill patients. This may bias our sample to a relatively healthy subpopulation of critically ill patients. Therefore, our results may not be extrapolated to other subgroups such as septic or trauma patients, where the unstressed volume might be substantially reduced, and the compliance substantially modified. Those patients may require a greater dose for an effective test. Fifth, patients were allocated to each group using a quasi-randomization approach, as defined by the Cochrane handbook (9) . This method of allocation increases the risk of systematic errors related to the environment that may interfere with the measurement process and selection bias. For that reason, a comparison of the baseline values and demographic characteristics was conducted, and it demonstrates a reasonable equality between groups. Nevertheless, a strict randomization would have added further robustness to this study.
CONCLUSION
The dose of fluids used for an FC can modify the proportions of responders in a cohort of postoperative patients. A dose of 4 mL/Kg increases Pmsf-arm beyond the limits of precision and reliably detects responders and nonresponders.
